About Us
| Company name | Holoeyes Inc. |
|---|---|
| Location |
〒107-0062 303 Morin Building, 2-17-3 Minami-Aoyama, Minato-ku, Tokyo |
| Company URL | https://holoeyes.jp/ |
| What we do | As a visualization and communication service for healthcare using VR technology, we provide applications and cloud services that convert 3D data generated from CT scans and MRIs into VR |
Field trial data
| Theme of field trail | Making active use of ICT (Information and Communication Technology) in Tokyo metropolitan hospitals |
|---|---|
| Tokyo site | Tokyo metropolitan hospitals |
| Product / Service Overview | We provide services that can be used for surgery examinations, training, education, etc. by converting 3D data generated from CT scans and MRIs into VR. When converting from 3D data to VR, users can easily access VR applications without the need for an engineer. |
| Outline of field trials | In metropolitan hospitals, VR-based 3D data will be used at conferences, surgery sites, for training of medical interns, and communication with patients to improve the efficiency of surgery, improve the effectiveness of training, and promote the understanding of patients. We plan to verify the effectiveness of the VR service on the efficiency of surgery and the effect on the degree of understanding of surgical staff and patients through surveys. |
Message from the CEO
Naotsugu Taniguchi
Along with the growing aging society, the medical technology that
responds to it is becoming more sophisticated. The necessity for
invasive surgeries is increasing, but the number of surgeons who
can perform these sophisticated surgeries is limited. Education
costs for nurses and biomedical equipment technicians are also
high. The current supply of medical human resources cannot meet
the demands of society.
By providing a service that converts
CT/MRI data into VR and records and reproduces surgery methods in 3D,
it is now possible to share personal skills and techniques with others.
Starting with Tokyo, we would like to support and help in providing
advanced medical technology to many patients.
In addition to
field trials, we also aim to establish an overseas business development
plan through the Tokyo Metropolitan Government and overseas public
administrations.